| 名稱 | 獲配股數 | 佔全球發售 | 佔上市後總股本 | 鎖定期 |
|---|---|---|---|---|
| Aranda Investments Pte. Ltd. | 0 | 3.75% | — | 6個月 |
| Boyu Capital Opportunities Master Fund | 0 | 2.50% | — | 6個月 |
| Double Joy Ventures Limited | 0 | 2.50% | — | 6個月 |
| Hillhouse Funds | 0 | 3.75% | — | 6個月 |
| Hudson Bay Master Fund LTD | 0 | 1.25% | — | 6個月 |
| Invesco Advisers, Inc. | 0 | 10.00% | — | 6個月 |
| Janchor Partners Pan-Asian Master Fund | 0 | 1.25% | — | 6個月 |
| Lake Bleu Prime Healthcare Master Fund Limited | 0 | 2.50% | — | 6個月 |
| LAV Fund VI | 0 | 2.50% | — | 6個月 |
| Octagon Investments Master Fund LP | 0 | 1.25% | — | 6個月 |
| Sage Partners Master Fund | 0 | 1.25% | — | 6個月 |
| Springhill Master Fund Limited | 0 | 1.25% | — | 6個月 |
| UBS Asset Management (Singapore) Ltd. | 0 | 10.00% | — | 6個月 |
| Yi Fang Da Sirius Inv. Limited | 0 | 1.25% | — | 6個月 |
| 佳曦控股有限公司 | 0 | 2.50% | — | 6個月 |
本頁展示 康诺亚生物医药科技有限公司 - B(02162)的打新中籤分析:一手中籤率、甲乙組中籤分佈、超額認購倍數、暗盤與首日表現。數據來自港交所配發結果公告。中籤率的計算方式與回撥規則見港股中籤率怎麼算。

